The Impact of the 2022 WHO Classification of Thyroid Neoplasms on Everyday Practice of Cytopathology

被引：0
|
作者：
Esther Diana Rossi
Zubair Baloch
机构：
[1] Policlinico Universitario A.Gemelli-IRCCS,Division of Anatomic Pathology and Histology
[2] Largo Agostino Gemelli, Fondazione
[3] 8 – 00168 ,Department of Pathology and Laboratory Medicine
[4] Hospital of the University of Pennsylvania,undefined
来源：
Endocrine Pathology | 2023年 / 34卷
关键词：
WHO; Thyroid cancers; Thyroid cytology; Thyroid diagnostic categories; Molecular testing; Personalized medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This review outlines how the alterations in the 5th edition of the WHO Classification of Endocrine and Neuroendocrine Tumors of the thyroid gland are likely to impact thyroid cytopathology. It is important to note that WHO subclassifies thyroid tumors into several new categories based on increased comprehension of the cell of origin, pathologic features (including cytopathology), molecular classification, and biological behavior. The 3rd edition of the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) will debut in the near future and will include changes in diagnostic category designations. The changes in the 5th edition of the WHO will in some instances subtly, and in other instances significantly, impact the cytological diagnoses. Moreover, these changes will also affect other thyroid FNA classification schemes used internationally for classifying thyroid FNA specimens.
引用
收藏
页码：23 / 33
页数：10
相关论文
共 40 条
  • [31] Parsing the thyroid cytopathology suspicious for malignancy diagnosis through molecular-derived risk of malignancy and other related parameters: Insights into nodule characteristics and practice patterns
    Starr, David
    Tjendra, Youley
    Torres, Jaylou M. Velez
    Gomez-Fernandez, Carmen
    Khader, Samer N.
    Karslioglu-French, Esra
    Yip, Linwah
    Carty, Sally E.
    Skaugen, John M.
    Nikiforov, Yuri E.
    Seethala, Raja R.
    Ohori, N. Paul
    CANCER CYTOPATHOLOGY, 2025, 133 (01)
  • [32] Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years
    Fujimori, Nao
    Miki, Masami
    Lee, Lingaku
    Matsumoto, Kazuhide
    Takamatsu, Yu
    Takaoka, Takehiro
    Teramatsu, Katsuhito
    Suehiro, Yuta
    Murakami, Masatoshi
    Igarashi, Hisato
    Oono, Takamasa
    Ohtsuka, Takao
    Nakamura, Masafumi
    Koga, Yutaka
    Oda, Yoshinao
    Ito, Tetsuhide
    Ogawa, Yoshihiro
    PANCREATOLOGY, 2020, 20 (04) : 709 - 715
  • [33] Assessment of the impact of glioma diagnostic reclassification following the new 2016 WHO classification on a series of cases
    Valera-Mele, Marc
    Mateo Sierra, Olga
    Sola Vendrell, Emma
    Guzman de Villoria L, Juan Adan
    Carvajal Diaz, Lorena
    Gil de Sagredo del Corral, Oscar Lucas
    Garcia Leal, Roberto
    NEUROCIRUGIA, 2019, 30 (01): : 19 - 27
  • [34] Impact of Psoriatic Arthritis on the Patient: Through the Lens of the WHO International Classification of Functioning, Health, and Disability
    William J. Taylor
    Current Rheumatology Reports, 2012, 14 : 369 - 374
  • [35] Impact of Psoriatic Arthritis on the Patient: Through the Lens of the WHO International Classification of Functioning, Health, and Disability
    Taylor, William J.
    CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (04) : 369 - 374
  • [36] Prognostic Impact of Ki-67 Index and WHO2017 Classification in Bronchopulmonary Neuroendocrine Neoplasm
    Kasajima, A.
    Oka, N.
    Konukiewitz, B.
    Suzuki, H.
    Sakurada, A.
    Okada, Y.
    Kameya, T.
    Ishikawa, Y.
    Sasano, H.
    Weichert, W.
    Kloppel, G.
    NEUROENDOCRINOLOGY, 2019, 108 : 106 - 106
  • [37] WHO classification 2016 and first S3 guidelines on renal cell cancer. What is important for the practice?
    Moch, H.
    PATHOLOGE, 2016, 37 (02): : 127 - 133
  • [38] An Evaluation of the Impact of Increasing the Awareness of the WHO Access, Watch, and Reserve (AWaRe) Antibiotics Classification on Knowledge, Attitudes, and Hospital Antibiotic Prescribing Practices
    Abu-Ajaleh, Salam
    Elhajji, Feras Darwish
    Al-Bsoul, Shatha
    Abu Farha, Rana
    Al-Hammouri, Fawzi
    Amer, Amer
    Al Rusasi, Ahmed
    Al-Azzam, Sayer
    Araydah, Mohammad
    Aldeyab, Mamoon A.
    ANTIBIOTICS-BASEL, 2023, 12 (06):
  • [39] WHO-Klassifikation von 2016 und erste S3-Leitlinie zum NierenzellkarzinomWas ist wichtig für die Praxis?WHO classification 2016 and first S3 guidelines on renal cell cancerWhat is important for the practice?
    H. Moch
    Der Pathologe, 2016, 37 (2): : 127 - 133
  • [40] A 15 year institutional experience of well-differentiated follicular cell-derived thyroid carcinomas; impact of the new 2017 TNM and WHO Classifications of Tumors of Endocrine Organs on the epidemiological trends and pathological characteristics
    Borda, Angela
    Zahan, Ancuta-Elena
    Piciu, Doina
    Barbus, Elena
    Berger, Nicole
    Nechifor-Boila, Adela
    ENDOCRINE, 2020, 67 (03) : 630 - 642
1234